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Myocardial	Infarc.on	
	
Introduc.on	
	
•  Cardiovascular	disease	is	a	term	
used	to	refer	to	pathologies	
affec5ng	the	structure	and	func5on	
of	the	heart	and	blood	vessels	
(Stewart,	Manmathan,	&	Wilkinson,	
2017).	The	most	common	type	of	
cardiovascular	disease	is	coronary	
artery	disease	(Center	for	Disease	
Control	and	Preven5on	[CDC],	
2017).			
•  A	serious	complica5on	of	coronary	
artery	disease	(CAD)	is	myocardial	
infarc5on	(MI),	commonly	known	as	
a	heart	aNack	(CDC,	2017).	It	is	
es5mated	that	in	the	United	States	
every	40	seconds	a	person	suffers	
from	a	myocardial	infarc5on,	
resul5ng	in	approximately	790,000	
myocardial	infarc5ons	every	year	
(CDC,	2017).		
•  Coronary	artery	disease	is	primarily	
considered	a	preventable	condi5on	
(Stewart,	Manmathan,	&	Wilkinson,	
2017).	As	an	intensive	care	unit	
nurse,	and	future	APRN	it	is	
impera5ve	to	understand	CAD	and	
the	associated	risk	factors	to	
effec5vely	care	for	and	educate	
pa5ents.	Pa5ent	educa5on	is	
pivotal	in	reducing	the	incidence	of	
myocardial	infarc5on	in	the	United	
States	through	risk	factor	
modifica5on.	
	
Case	Study	
	
•  A	57-year-old	man	presents	to	the	
emergency	room	with	complaints	
of	chest	pain	and	shortness	of	
breath	that	started	30	minutes	ago.		
The	pa5ent	is	pale	and	diaphore5c,	
and	is	now	complaining	of	nausea.		
A	health	history	reveals	the	pa5ent	
has	type	2	diabetes	mellitus,	
hypertension,	and	dyslipidemia.		An	
electrocardiogram	(ECG)	is	
completed,	which	shows	ST	
segment	eleva5on	in	leads	II,	III,	
and	aVF.	A	hospital	wide	STEMI	
alert	is	ini5ated,	no5fying	the	
interven5onal	cardiologist	and	
cardiac	cath	lab.	The	emergency	
room	staff	begins	prepping	the	
pa5ent	for	emergent	percutaneous	
coronary	interven5on	(PCI).		
Significance	of	
Pathophysiology	
	
•  Myocardial	infarc5on	is	a	5me	
sensi5ve	condi5on	that	requires	
interven5on	to	restore	coronary	
blood	flow.	The	affected	
myocardium	becomes	cyano5c	
within	8	to	seconds	of	decreased	
blood	flow.	ECG	changes	become	
visible	within	30	to	60	seconds	of	
hypoxia.		Aaer	approximately	20	
minutes	of	ischemia,	cellular	death	
occurs	(McCance	&	Huether,	
2018).		
•  The	amount	of	damage	to	the	
myocardium	depends	on	the	
loca5on	of	the	infarct	and	length	of	
5me	before	reperfusion		(Davies,	
2016).		
•  Poten5al	complica5ons	of	
myocardial	infarc5on	include	
cardiogenic	shock,	heart	failure,	
mitral	valve	regurgita5on,	
ventricular	septal	rupture,	
dysrhythmias,	pericardi5s,	and	
sudden	death	(O’Gara	et	al.,	2013).	
•  Understanding	the	
pathophysiology	of	myocardial	
infarc5on	provides	nurses	and	
healthcare	providers	with	the	
knowledge	required	to	educate	
pa5ents	on	how	to	recognize	signs	
and	symptoms	of	a	MI,	and	how	a	
MI	can	be	prevented.	
	
	
.	
Underlying		
Pathophysiology	
	
•  The	heart	receives	oxygenated	
blood	from	the	aorta	via	the	
coronary	arteries.	Myocytes	also	
known	as	muscle	cells,	require	a	
con5nuous	supply	of	oxygenated	
blood	for	proper	func5oning.	
(Davies,	2016).	
•  Atherosclerosis	is	a	process	
through	which	lipid-laden	
macrophages	accumulate	within	
the	arterial	wall	to	form	a	lesion	
called	a	plaque,	resul5ng	in	
thickening	and	hardening	of	the	
vessel	(McCance	&	Huether,	2018).	
•  Coronary	artery	disease	is	a	
narrowing	of	the	coronary	arteries,	
most	commonly	caused	by	
atherosclerosis	(Andrus	et	al.,	
2015).	
•  Myocardial	ischemia	occurs	when	
the	coronary	arteries	are	unable	to	
deliver	enough	oxygen	and	
nutrients	to	meet	the	demand	of	
the	myocardium	(McCance	&	
Huether,	2018).	
•  When	ischemia	to	the	myocardium	
is	prolonged,	myocardial	infarc5on	
occurs	resul5ng	in	irreversible	
damage	and	necrosis	of	the	
myocardium.	Damage	to	the	
myocardium	can	result	in	abnormal	
electrical	impulses,	decreased	
contrac5lity,	and	impaired	ejec5on	
of	blood	into	the	pulmonary	and/or	
systemic	circula5on	(Davies,	2016).			
•  Myocardial	infarc5on	can	be	
classified	clinically	as	a	non-ST-
eleva5on	MI	(NSTEMI)	or	ST-
eleva5on	MI	(STEMI).	Both	
classifica5ons	have	specific	
treatment	guidelines	that	include	
an5thrombo5c	therapy	and	PCI.	
Percutaneous	coronary	
interven5on	includes	angioplasty,	
stent	placement,	and	
thrombectomy.		
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Signs	&	Symptoms	
	
•  Chest	pain	or	discomfort	
	
	
	
•  Dyspnea	
•  Fa5gue	
•  Lightheadedness	
•  Pallor		
•  Diaphoresis	
•  Palpita5ons	
•  Nausea	with	possible	vomi5ng	
•  Low	grade	pyrexia	
•  Hypotension	or	hypertension	
•  Atypical	symptoms	are	oaen	
present	in	older	people,	women,	
and	individuals	with	diabetes	(Peate	
&	Jones,	2014;	McCance	&	Huether,	
2018).	
	
Treatment	
	
•  NSTEMI:	administra5on	of	
an5platelet	and	an5coagulant,	
possible	PCI	(McCance	&	Huether,	
2018)	
•  STEMI:	early	reperfusion	therapy	
with	administra5on	of	an5platelet	
and	an5coagulant,	and	PCI.	If	PCI	is	
unavailable	administra5on	of	a	
fibrinoly5c	(O’Gara	et	al.,	2013)	
	
Implica.ons	for	
Nursing	Care	
	
•  Recognize	signs	and	symptoms	of	
myocardial	ischemia	and	infarc5on	
•  Con5nuous	monitoring	for	new	ECG	
changes	
•  Frequent	monitoring	of	BP,	HR,	
respira5on	rate,	and	SpO2	
•  Cardiac	assessment	for	abnormal	
heart	sounds	(S3,	S4),	strength	of	
pulses,	presence	of	jugular	venous	
disten5on,	skin	color	and	
temperature	(Peate	&	Jones,	2014)	
•  Pulmonary	assessment	for	breath	
sounds,	presence	of	crackles,	
respiratory	effort,	and	shortness	of	
breath	(Peate	&	Jones,	2014)	
•  Administra5on	of	medica5ons,	
which	could	include	an5platelet	
therapy,	an5coagulants,	nitrates,	
diure5cs,	inotropes,	and	analgesics	
(Rollini	&	Angiolillo,	2015;	Peaste	&	
Jones,	2014).	
•  Monitor	PCI	access	site	for	
complica5ons	such	as	bleeding,	
hematoma,	pseudoaneurysm,	or	
retroperitoneal	bleeding	(O’Gara	et	
al.,	2013).	Complica5ons	should	be	
immediately	reported	to	the	
healthcare	provider.			
•  Manage	hemostasis	device	or	
arterial	sheath	as	indicated.	
•  Pa5ent	educa5on	is	essen5al	for	a	
pa5ent	who	has	been	diagnosed	
with	a	myocardial	infarc5on.		
Educa5on	should	focus	on	how	to	
take	medica5ons	including	why	
they	were	prescribed,	diet	
modifica5on,	exercise,	smoking	
cessa5on,	and	management	of	
other	risk	factors.	The	pa5ent	
should	also	be	educated	on	cardiac	
rehabilita5on	programs	and	when	
to	follow	up	with	a	physician	
(Aroesty	&	Kannam,	2018).	
	
	
Diagnosis	
	
According	to	the	Fourth	Universal	Defini5on	
of	Myocardial	Infarc5on,	a	diagnosis	of	
myocardial	infarc5on	is	appropriate	when	
there	is	acute	myocardial	injury	detected	by	a	
rise	and/or	fall	of	cardiac	troponin	(cTn)	
values	with	at	least	1	value	above	the	99th	
percen5le	upper	reference	limit	(URL),	and	
clinical	evidence	of	acute	myocardial	ischemia	
as	evidenced	by	at	least	one	of	the	following	
(Thygesen	et	al.,	2018):	
	
•  Symptoms	of	myocardial	ischemia	
•  Electrocardiographic	changes	indica5ng	
new	or	presumed	new	ischemia	(ST-
segment	changes,	T-wave	changes	or	
lea	bundle	branch	block)	
•  Development	of	pathological	Q	waves	
on	electrocardiogram		
•  Imaging	evidence	of	viable	myocardium	
loss	or	new	regional	wall	mo5on	
abnormality	
•  Coronary	thrombus	iden5fied	by	
angiography	or	autopsy	
									(Thygesen	et	al.,	2018)	
•  NSTEMI:	plaque	
rupture/erosion	with	
non-occlusive	
thrombosis	
•  STEMI:	plaque	
rupture/erosion	with	
occlusive	thrombosis	
(Thygesen	et	al.,	2018)	
Modifiable	Risk	
Factors	
	
•  Diabetes	mellitus	
•  Dyslipidemia	
•  Hypertension	
•  Overweight	and	obesity		
•  Unhealthy	diet	and	sedentary	
lifestyle	
•  Smoking	
(Peate	&	Jones,	2014)	
		
	
Non-modifiable	
Risk	Factors	
	
•  Advanced	age	
•  Male	gender	
•  Family	history	
•  Race	
(Peate	&	Jones,	2014)	
Conclusions	
	
Myocardial	infarc5on	is	a	life	
threatening	condi5on	that	requires	
early	interven5on.		If	coronary	blood	
flow	is	not	quickly	restored,	
myocardial	ischemia	will	progress	to	
cell	death	and	necrosis	(Thygesen	et	
al.,	2018).		Healthcare	providers	must	
be	able	to	recognize	the	signs	and	
symptoms	of	a	myocardial	infarc5on	
so	early	reperfusion	therapy	can	be	
ini5ated	to	reduce	morbidity	and	
mortality.	
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Figure	1.	Development	of	atherosclerosis.	(Mayo	Clinic,	2019)	
Figure	2.		Myocardial	infarction	
due	to	an	occlusive	thrombus	
(Mayo	Clinic,	2018).	
•  Pain	characteris5cs	vary	
among	pa5ents,	and	is	
frequently	described	as	
crushing,	substernal	
pressure,	or	squeezing.		
•  Radia5on	to	the	arm,	
shoulder,	neck,	or	jaw	is	
common,	oaen	to	the	lea	
side.	
